Evidence map›Paper›PMID 9343428›Full record

ArticleMolecular and cellular biology1997

Processing of targeted psoralen cross-links in Xenopus oocytes.

D J Segal, A F Faruqi, P M Glazer, D Carroll

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

D J SegalDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City 84132, USA.
A F Faruqi
P M Glazer
D Carroll
University of Utah · USYale University · US

Funding

TARGETED MUTAGENESIS OF DNA VIA TRIPLE HELIX FORMATIONR01CA064186 · NCI · YALE UNIVERSITY · PI GLAZER, PETER M · 1995 to 2008
$2.6M
VERTEBRATE GENE TARGETING--A MODEL SYSTEMR01GM050739 · NIGMS · UNIVERSITY OF UTAH · PI CARROLL, DANA · 1994 to 1996
–
NCI NIH HHS CA64186NIGMS NIH HHS GM50739
6 · The paper itself

Abstract

Psoralen cross-links have been shown to be both mutagenic and recombinagenic in bacterial, yeast, and mammalian cells. Double-strand breaks (DSBs) have been implicated as intermediates in the removal of psoralen cross-links. Recent work has suggested that site-specific mutagenesis and recombination might be achieved through the use of targeted psoralen adducts. The fate of plasmids containing psoralen adducts was evaluated in Xenopus oocytes, an experimental system that has well-characterized recombination capabilities and advantages in the analysis of intermediates in DNA metabolism. Psoralen adducts were delivered to a specific site by a triplex-forming oligonucleotide. These lesions are clearly recognized and processed in oocytes, since mutagenesis was observed at the target site. The spectrum of induced mutations was compared with that found in similar studies in mammalian cells. Plasmids carrying multiple random adducts were preferentially degraded, perhaps due to the introduction of DSBs. However, when DNAs carrying site-specific adducts were examined, no plasmid loss was observed and removal of cross-links was found to be very slow. Sensitive assays for DSB-dependent homologous recombination were performed with substrates with one or two cross-link sites. No adduct-stimulated recombination was observed with a single lesion, and only very low levels were observed with paired lesions, even when a large proportion of the cross-links was removed by the oocytes. We conclude that DSBs or other recombinagenic structures are not efficiently formed at psoralen adducts in Xenopus oocytes. While psoralen is not a promising reagent for stimulating site-specific recombination, it is effective in inducing targeted mutations.

Indexed as

MutagenesisMutagenesis, Site-DirectedAnimalsCross-Linking ReagentsDNA AdductsDNA DamageDNA RepairFurocoumarinsMicroinjectionsModels, GeneticOocytesPlasmidsRecombination, GeneticXenopusCross-Linking ReagentsDNA AdductsFurocoumarins

Identifiers

PMID9343428
PMCPMC232518
OpenAlexW2118689054

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.